REST and Stroke: miR-124 targets USP14 to suppresses deubiquitination of REST, which contributes to reduced brain injury and functional impairment, enhanced neurovascular remodeling, and increased angioneurogenesis 8 weeks post-stroke in mice with MCAO (Doeppner et al., 2013).